中国实用外科杂志

• 述评 • 上一篇    下一篇

肠瘘诊治若干焦点问题

王革非,吴    磊,任建安   

  1. 南京大学医学院附属金陵医院(中国人民解放军东部战区总医院) 中国人民解放军普通外科研究所,江苏南京 210002
  • 出版日期:2025-03-01

  • Online:2025-03-01

摘要: 肠瘘是胃肠外科手术后的常见并发症,具有较高的致死率。其发生通常由于消化液外漏,导致腹腔感染、脓毒症、多器官功能衰竭等一系列严重并发症。肠瘘的病理生理特征与其治疗密切相关。根据不同的病理生理变化,肠瘘可分为危重型和稳定型。危重型肠瘘通常发生在病程早期,死亡率较高,而稳定型肠瘘则为经过初步控制的病情,主要面临消化液丧失等相关问题。肠瘘的发生还可能引发一系列并发症,包括腹腔压力升高、肺部感染和肾功能衰竭等。对于肠瘘的诊断,早期发现至关重要。直接征象如消化液外漏和腹腔感染症状变化,以及间接征象如消化酶腐蚀等都可以作为诊断依据。诊断的及时性对制定治疗方案起着决定性作用,能有效避免病死率的上升。随着内镜技术的不断进步,肠瘘的治疗方法逐渐多样化,内镜下的负压治疗和黏膜清创等新技术为肠瘘的自愈提供了更多可能。在治疗方面,肠瘘的管理需要分阶段进行。危重病情阶段应以挽救生命为首要任务,采取液体管理、抗感染治疗、感染源控制等综合手段;病情逐步稳定后,治疗重点转向促进自愈,减少手术干预的必要性,辅以营养支持和预康复治疗。尽管阶段性治疗策略已在实践中取得初步成效,但肠瘘的治疗仍面临许多挑战,特别是在个体化治疗和长期管理方面。未来的研究应进一步探索肠瘘的病理生理特征及治疗方案的优化,以期实现更高的治愈率和更好的病人预后。

关键词: 肠瘘, 腹腔感染, 内镜治疗, 预康复, 病理生理, 并发症, 诊治策略

Abstract: Enterocutaneous fistula is a common complication following gastrointestinal surgery, with a high mortality rate. Its occurrence typically results from the leakage of digestive fluids, leading to intra-abdominal infections, sepsis, multiple organ failure, and other severe complications. The pathophysiological characteristics of enterocutaneous fistula are closely related to its treatment. Based on different pathophysiological changes, enterocutaneous fistula can be classified into critical and stable types. Critical enterocutaneous fistulas typically occur in the early stages of the disease and have a higher mortality rate, while stable enterocutaneous fistulas refer to those in which the condition has been initially controlled, primarily facing issues such as fluid loss. The occurrence of enterocutaneous fistula can also trigger a series of complications, including increased intra-abdominal pressure, pulmonary infections, and renal failure. Early detection is crucial for the diagnosis of enterocutaneous fistula. Direct signs, such as the leakage of digestive fluids and changes in symptoms of intra-abdominal infection, as well as indirect signs like digestive enzyme corrosion, can all serve as diagnostic criteria. The timeliness of diagnosis plays a decisive role in formulating an effective treatment plan, which can significantly reduce the mortality rate. With the continuous advancement of endoscopic technology, treatment methods for enterocutaneous fistula have become more diverse. New techniques, such as endoscopic negative pressure therapy and mucosal debridement, provide more possibilities for the self-healing of the fistula. In terms of treatment, the management of enterocutaneous fistulas requires a staged approach. In the critical phase, the primary goal should be lifesaving, utilizing comprehensive measures such as fluid management, anti-infection therapy, and infection source control. As the condition stabilizes, the focus of treatment shifts to promote self-healing, reduce the need for surgical intervention, and provide nutritional support and pre-rehabilitation therapy. Although staged treatment strategies have shown preliminary success in practice, the treatment of enterocutaneous fistulas still faces many challenges, particularly in terms of personalized treatment and long-term management. Future research should further explore the pathophysiological characteristics of enterocutaneous fistulas and optimize treatment plans to achieve higher cure rates and better patient outcomes.

Key words: enterocutaneous fistula, abdominal infection, endoscopic treatment, prehabilitation, pathophysiology, complications, diagnosis and treatment strategy